Essel's consolidated sales growth of ~17% YoY was led by strong performance of all regions, largely on a lower base wherein performance of Amesa and Europe region was hurt by GST led transition (in India) and lower volume offtake by key customer in Europe. In Q3FY19, revenue contribution of non-oral category to consolidated sales increased from 41.3% in Q3FY18 to 43.5% in Q3FY19. According to management, Amesa region (contributes 38% to topline) will record healthy performance, going forward, as...